Intravenous Gammaglobulin Treatment in HIV-1 Infection

Immunology and Allergy Clinics of North America

Volumn 28, Issue 4, 2008, Pages 851-859

  Deener, Avi ^a   Mehra, Ami ^a   Bernstein, Larry ^a   Shliozberg, Jenny ^a   Rubinstein, Arye ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; B cells; Highly active antiretroviral therapy (HAART); HIV 1; Immunodeficiency; Opportunistic infections; T cells; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACEBO; PNEUMOCOCCUS VACCINE; RHESUS D ANTIBODY; STEROID; THROMBOCYTE ANTIBODY; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGAMMAGLOBULINEMIA; ANTIBODY RESPONSE; AUTOIMMUNE THROMBOCYTOPENIA; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY OF MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; KAPOSI SARCOMA; LOW DRUG DOSE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; STREPTOCOCCUS INFECTION; SUBSTITUTION THERAPY; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

ADULT; B-LYMPHOCYTES; CHILD; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; PREGNANCY;

EID: 53649095064     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2008.06.001     Document Type: Review

References (49)

1. Rubinstein A., Sicklick M., Gupta A., et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249 (1983) 2345-2349
2. Rubinstein A. Acquired immunodeficiency syndrome in infants. [editorial]. Am J Dis Child 137 (1983) 825-826
3. Rubinstein A., Bernstein L., and Small C. Autoantibodies to AIDS-T cells. Ann N Y Acad Sci 437 (1985) 508-509
4. Bernstein L., Krieger B.Z., Novick B., et al. Bacterial infection in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis 4 (1985) 472-475
5. Bernstein L., Ochs H., Wedgewood R., et al. Defective humoral immunity in children with AIDS. J Pediatr 107 (1985) 352-357
6. Rubinstein A., Calvelli T., and Rubinstein R. Intravenous gammaglobulin for pediatric HIV-1 infection: effects on infectious complications, circulating immune complexes and CD4 cell decline. Ann N Y Acad Sci 693 (1993) 151-157
7. Calvelli T., and Rubinstein A. Immunodeficiency: pediatric AIDS. In: Rosen F.S. (Ed). Clinical aspects of immunology. 5th edition (1993), Blackwell Scientific Publication, Ltd, Oxford, England 1341-1368
8. Calvelli T.A., and Rubinstein A. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis 5 (1986) S207-S208
9. Ellaurie M., Calvelli T., and Rubinstein A. Human immunodeficiency virus (HIV) circulating immune complexes in infected children. AIDS Res Hum Retroviruses 6 (1990) 1437-1444
10. Ellaurie M., Calvelli T., and Rubinstein A. Neopterin levels in pediatric HIV infection as predictor of disease activity. Pediatr Infect Dis J 11 (1992) 286-289
11. Ellaurie M., and Rubinstein A. Tumor necrosis factor in pediatric HIV-1 infection. AIDS 6 (1992) 1265-1268
12. Gupta A., Novick M.E., and Rubinstein A. Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment. Am J Dis Child 140 (1986) 143-146
13. Ellaurie M., Calvelli T., and Rubinstein A. Immune complexes in pediatric HIV infection. Am J Dis Child 144 (1990) 1207-1209
14. Ellaurie M., and Rubinstein A. Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection. Pediatr Infect Dis 9 (1990) 807-809
15. 1 activity in pediatric acquired immunodeficiency ayndrome (in vivo and in vitro studies). J Pediatr 109 (1986) 422-427
16. Rubinstein A., Mizrachi Y., Bernstein L., et al. Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage φX174 in asymptomatic HIV-1 infected patients. AIDS 14 (2000) F55-F62
17. Silverman B., and Rubinstein A. Serum lactate dehydrogenase in adults and children with AIDS and ARC: possible indicator of B cell proliferation and disease activity. Am J Med 78 (1985) 728-736
18. The NCHD Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic HIV infection. N Engl J Med 325 (1991) 73-80
19. Mofenson L.M., Moye Jr. J., Bethel J., et al. Prophylactic intravenous gammaglobulin in HIV-infected children with CD4+ counts of 0.20/L or more. JAMA 268 (1992) 483-488
20. Mofenson L.M., Moye Jr. J., Korelitz J., et al. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in HIV-infected children. Pediatr Infect Dis J 13 (1994) 477-484
21. Mofenson L.M., Bethel J., Moye Jr. J., et al. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. J Acquir Immune Defic Syndr 6 (1993) 1103-1113
22. Ellaurie M.D., Shah K., Bernstein L.J., et al. Thrombocytopenia in pediatric AIDS. Pediatrics 82 (1988) 905-908
23. Burns E.R., Lee V., and Rubinstein A. Treatment of septic thrombocytopenia with immune globulin. J Clin Immunol 11 (1991) 363-368
24. Ellaurie M., Burns E.R., and Rubinstein A. Platelet associated IgG in pediatric HIV infection. Pediatr Hematol Oncol 8 (1991) 179-185
25. Burns E.R., Krieger B.Z., Bernstein L., et al. Acquired circulating anticoagulants in pediatric AIDS. Pediatrics 82 (1988) 763-765
26. Yap P.L. Does intravenous immune globulin have a role in HIV-infected patients?. Clin Exp Immunol 97 Suppl 1 (1994) 59-67
27. Polsky B., Gold J.W.M., Whimbey E., et al. Bacterial pneumonias in patients with AIDS. Ann Intern Med 104 (1986) 38-41
28. Selwyn P.A., Feingold A.R., Hartel D., et al. Increased risk of bacterial pneumonias in HIV-infected intravenous drug users without AIDS. AIDS 2 (1988) 267-272
29. Janoff E.N., Breiman R.F., Daley C.L., et al. Pneumococcal disease during HIV infection: epidemiologic, clinical and immunologic perspectives. Ann Intern Med 117 (1992) 314-324
30. Schrappe-Bacher M., Rasokat H., Bauer P., et al. High dose intravenous gammaglobulin in HIV-infected adults with AIDS-related complex and Walter Reed 5. Vox Sang 59 Suppl 1 (1990) 3-14
31. Fine M.J., Smith M.A., Carson C.A., et al. Efficacy of pneumococcal vaccination: a meta-analysis of randomized controlled trials. Arch Intern Med 154 (1994) 2666-2677
32. French N., Nakiyingi J., Carpenter L.M., et al. 23 Valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: double-blind, randomized and placebo controlled trial. Lancet 355 (2000) 2106-2111
33. Pettoello-Mantovani M., Casadevall A., Kollmann T.R., et al. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 339 8784 (1992) 21(1)-3
34. Brichachek B., Swindells S., Janoff E.N., et al. Increased plasma HIV-1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 174 (1996) 1191-1199
35. Morris L., Distenfeld A., Amorosi E., et al. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 96 (1982) 714-717
36. Simpson K.N., Coughlin C.M., Eron J., et al. Idiopathic thrombocytopenia purpura: treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy. Semin Hematol 35 1 (1998) 58-64
37. Cai J., Zheng T., Lotz M., et al. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor. Blood 89 (1997) 1491-1497
38. Gyongyossy-Issa M.I., Bussel J.B., Carter C.J., et al. Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment. Platelets 14 5 (2003) 267-276
39. Oksenhendler E., Bierling P., Brossard Y., et al. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura. Blood 71 5 (1988) 1499-1502
40. Majluf-Cruz A., Luna-Castaños G., Huitrón S., et al. Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS. Blood 82 5 (1993) 1415-1421
41. Scaradavou A., Cunningham-Rundles S., Ho J.L., et al. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison. Am J Hematol 82 5 (2007) 335-341
42. Lesprit P., Pédrono G., Molina J.M., et al., ANRS 114-Pneumovac Study Group. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS 21 18 (2007) 2425-2434
43. Viard J.P., Vittecog D., Lacroix C., et al. Response of HIV-1 associated polymyositis to intravenous gammaglobulin. Am J Med 92 (1992) 580-581
44. Smith K.Y., Valdez H., Landay A., et al. Thymic size and lymphocyte restoration in HIV infected patients following 48 weeks of therapy with zidovudine, lamivudine and ritonavir. J infect Dis 181 (2000) 141-147
45. Arpadi S.M., Markowitz L.E., Baughman A.L., et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 97 5 (1996) 653-657
46. Moir S., Ogwaro K.M., Malaspina A., et al. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals. Proc Natl Acad Sci USA 10 (2003) 6057-6062
47. Bekker V., Scherpbier H., Pajkrt D., et al. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118 2 (2006) e315-e322
48. Rosenblatt H.M., Song L.Y., Nachman S.A., et al. Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection. J Allergy Clin Immunol 116 (2005) 698-703
49. Hart M., Steel A., Clark S.A., et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 178 (2007) 8212-8220